Topic: Colchicine

1 chapters across the catalog

Ask China!
Episode 1350 50:30 - 55:22

1350: Ask China!

Global Suppression of Colchicine, Medical Licensing Threats

The Colchicine trial, described as a high-quality double-blind study, was reportedly rejected by major journals like The Lancet and JAMA. In Canada and Australia, doctors face threats of license revocation or jail time for attempting to treat COVID-19 outpatients with repurposed drugs. South Africa has reportedly jailed doctors for using ivermectin.